Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$0.01 - $0.61 $3 - $204
-335 Reduced 2.02%
16,215 $0
Q4 2023

Feb 14, 2024

SELL
$0.42 - $0.72 $627 - $1,075
-1,494 Reduced 8.28%
16,550 $10,000
Q3 2023

Nov 13, 2023

SELL
$0.6 - $1.53 $44,860 - $114,395
-74,768 Reduced 80.56%
18,044 $11,000
Q2 2023

Aug 14, 2023

BUY
$1.05 - $1.63 $80,081 - $124,316
76,268 Added 461.0%
92,812 $104,000
Q1 2023

May 15, 2023

SELL
$1.2 - $2.73 $5,289 - $12,033
-4,408 Reduced 21.04%
16,544 $22,000
Q4 2022

Feb 08, 2023

SELL
$1.71 - $3.61 $1,347 - $2,844
-788 Reduced 3.62%
20,952 $39,000
Q3 2022

Nov 15, 2022

BUY
$1.9 - $8.63 $596 - $2,709
314 Added 1.47%
21,740 $53,000
Q2 2022

Aug 10, 2022

SELL
$2.13 - $9.01 $75,421 - $319,035
-35,409 Reduced 62.3%
21,426 $52,000
Q1 2022

May 10, 2022

BUY
$6.28 - $15.59 $5,111 - $12,690
814 Added 1.45%
56,835 $453,000
Q4 2021

Feb 04, 2022

SELL
$14.7 - $28.67 $84,392 - $164,594
-5,741 Reduced 9.3%
56,021 $855,000
Q3 2021

Nov 10, 2021

BUY
$24.31 - $33.6 $40,719 - $56,280
1,675 Added 2.79%
61,762 $1.76 Million
Q2 2021

Aug 10, 2021

BUY
$26.09 - $40.4 $41,248 - $63,872
1,581 Added 2.7%
60,087 $2.03 Million
Q1 2021

Aug 10, 2021

BUY
$33.06 - $56.93 $3,306 - $5,693
100 Added 0.17%
58,506 $2.24 Million
Q1 2021

May 11, 2021

SELL
$33.06 - $56.93 $135,711 - $233,697
-4,105 Reduced 6.57%
58,406 $2.23 Million
Q4 2020

Feb 12, 2021

SELL
$39.09 - $57.4 $11,961 - $17,564
-306 Reduced 0.49%
62,511 $2.61 Million
Q3 2020

Dec 10, 2020

SELL
$28.43 - $44.67 $460,338 - $723,296
-16,192 Reduced 20.49%
62,817 $2.72 Million
Q2 2020

Aug 10, 2020

SELL
$11.71 - $30.29 $88,188 - $228,113
-7,531 Reduced 8.7%
79,009 $2.39 Million
Q1 2020

May 18, 2020

SELL
$7.64 - $27.5 $17,381 - $62,562
-2,275 Reduced 2.56%
86,540 $1.18 Million
Q4 2019

Feb 13, 2020

SELL
$15.02 - $20.57 $600 - $822
-40 Reduced 0.05%
88,815 $1.43 Million
Q3 2019

Nov 12, 2019

BUY
$18.85 - $27.5 $103,769 - $151,387
5,505 Added 6.6%
88,855 $1.71 Million
Q2 2019

Aug 14, 2019

SELL
$17.37 - $26.27 $136,910 - $207,060
-7,882 Reduced 8.64%
83,350 $1.96 Million
Q1 2019

Apr 23, 2019

BUY
$10.65 - $25.75 $106,627 - $257,809
10,012 Added 12.33%
91,232 $2.14 Million
Q1 2019

Apr 12, 2019

BUY
$10.65 - $25.75 $864,993 - $2.09 Million
81,220 New
81,220 $898,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Mercer Global Advisors Inc Portfolio

Follow Mercer Global Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.